Good news for multinational drugmakers: After bracing for China’s expanded government procurement scheme and the price cuts destined to come with it, the countrywide rollout turned out to be less terrible than some had feared.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,